Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
Bhel at centrestage after robust Q2 result     Back
(08:31, 14 Nov 2019)

Bharat Heavy Electricals (Bhel) reported 40.74% rise in consolidated net profit to Rs 121.70 crore on 8.18% fall in total income to Rs 6367.03 crore in Q2 September 2019 over Q2 September 2018.

Bharti Airtel, Grasim Industries, Vedanta and ONGC will unveil their quarterly results today, 14 November 2019.

Indiabulls Housing Finance said that the company has made timely payment of interest / principal (as the case may be) in respect of Secured Redeemable Non- Convertible Debentures (NCDs) issued by company, on private placement basis.

Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at Pashamylaram, Hyderabad, from 4 to 13 November 2019. At the end of the inspection, the company was issued a 'Form 483' with 14 observations. None of these observations are related to data integrity issues. The company will respond to the US FDA within the stipulated timeline.

Cadila Healthcare reported 74.32% fall in consolidated net profit to Rs 107.20 crore on 13.43% rise in total income to Rs 3393.50 crore in Q2 September 2019 over Q2 September 2018.

Blue Star reported 94.07% rise in consolidated net profit to Rs 37.94 crore on 21.5% rise in total income to Rs 1260.07 crore in Q2 September 2019 over Q2 September 2018.

Bata India reported 29.97% rise in consolidated net profit to Rs 71.30 crore on 7.53% rise in total income to Rs 739.67 crore in Q2 September 2019 over Q2 September 2018.

Top